News
Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...
Shares in European pharmaceutical firms slumped following a threat by President Donald Trump to punish them if they don't ...
The Trump administration is planning a five-year test allowing states to cover weight-loss drugs like Ozempic and Wegovy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback